归创通桥-B中期报告 2024

2452946474850515287 202466202466202466202466 202466202466 22 270 270 202466202466 3485 96827 128 H 9984 1617 H02190 168 www.zyloxtb.com 195 998 1811 I. 2024 366.0364.1202358.2%66.9%33.1% 202346.7%(i)CRDPTA(Rx)(ii)(iii) 202388.2%UltraFreePTA(UltraFreeDCB)ZENFLOWPTAZENFLOWPTAZYLOX Swan(i)(ii)ZYLOX PenguinZYLOX Phoenix2024 78.268.9 1. 202459.0%4420203,000600,000 5“3+N”ABCRD33% 2. 202411.5202384.2% 22ZYLOX PenguinCEMDR 2024(WLNC 2024)2024(LINC 2024) 3. 2021372024 ——ZYLOX PenguinZYLOX SwanZYLOX Octoplus—ZYLOX Unicorn5F26F ———UberVanaDCB—PTA—PTA 4. 68.9 202471.3% 202332.6%202421.9% 2024101.5202322.4% 202350.4202443.6 6344CE(UAE) 232027 (CRD)(BGC)BADDASSBADDASSBAlloon guide with large boreDistal access catheter with Dual Aspiration with Stent-retriever as Standard approach CRD BADDASSCRD CRD 2024 20243 80% 2025 90% 30%-50%20191,73020302,7902026 21202812 PTA —UltraFreePTA(UltraFree DCB) UltraFree DCB202011202010CE2021UltraFree DCB —UberVanaDCB DCBUberVanaDCB PTA20%CEUAEUltraFreeDCBPTA ZYLOX Swan 6F51202020228 ZYLOX Octoplus ZYLOX Octoplus(PE)(DVT) ZYLOX Penguin 420241 ZYLOX Unicorn ZYLOX Unicorn3–0ZYLOX Unicorn5F–22F8F 201510.75201927.432030378.21ZYLOX Unicorn20245 Avinger 20243Avinger Inc.AvingerAvinger Inc.(i) PantherisISR(ii) Tigereye ST(iii) LightBox 3OCT2025PantherisLightBox3OCT Avinger Pantheris OCT 2019PAD4,95020236,230PAD80% Pantheris(OCT)PAD(MAE)Pantheris(ISR)IDEVISION StudyINSIGHT Study Pantheris DCBDCB Pantheris OCT Tigereye ST Tigereye ST(CTO)OCTCTO Tigereye ST LightBox 3 OCT LightBox 3 OCTPatherisTigereye ST(OCT)CTO OCTLightboxXPADOCT LightBox 3 OCT 4,000(DCB)leave nothing behindTackMulti-LOC ePTFE ePTFETASC C/D II. 366.0364.1202358.2%66.9%33.1% 202346.7%(i)CRDPTA(Rx)(ii)(iii) 202388.2%UltraFreePTA(UltraFreeDCB)ZENFLOWPTAZENFLOWPTAZYLOX Swan(i)(ii)ZYLOX PenguinZYLOX Phoenix2024 105.120236 3059.576.6%(i)20236 30(ii) 20236 30170.652.9%260.920236 3074.2%71.3%(i)(ii) 101.520236 30130.822.4%20236 3055.640.9 80.020236 3074.96.7%20236 3032.6%21.9%(i)(ii)(iii) 43.620236 3050.413.4%202321.9%11.9% 0.620236 300.6 10.620236 305.2104.7% 9.220236 306.8 33.420236 3038.914.3% 20246 3020236 300.3100.0% (1)H 20246 30532.6202312 311,086.651.0%20246301,796.3202312 311,388.420246 30255.1202312 31102.1202312 312,577.120246 302,584.0 20246 3075.0202312 3150.050.0% 20246 3075.02.95%3.40% 20246 302.61%202312 311.83%42.5% 20246 301,021.2202312 311,399.427.0% 20246 30 20246 30121.9 20246 30 20246 30 20246 3075620236 30707 20246 3036.1168.720246 30 III. • • • (CRD)ZYLOX PenguinZYLOXUnicorn • 20236 632,461,974H202366H10%108,000H971,090 20247312,219,000H108,000H20232,111,000H322,400,744H683,5007,781,257 C1 C.2.1C.2.1 C3 20247 1683,500H7,540,11020246 30 3.10(2)3.2120246 30 2410 2,477.42,063.620217 28347.3289.7 20246 6 20246 6 20245 9 20246 3013.51B(1) 1818 18 20246 30XVXV78352 (1)7,781,25720246 30324,619,744HL (2)WEAEnterprises, LLCWEA20211 21II 20246 309,136,780H1,015,1985,114,645H568,2949,862,718H1,095,8578,619,386H957,709 (3)Highlight Medical LimitedHighlight MedicalOurea Biotech HK LimitedOurea BiotechFive Investment LimitedFive InvestmentHomehealth Investment LimitedHomehealth20213 11IIIIFive InvestmentFive InvestmentHighlight Medical HomehealthHighLightCapital Partners I L.P.HighLight Capital Partners I L.P.HighLight Capital GP I Company LimitedHighLight Capital Partners I L.P.HighLight Capital GP I Company LimitedFive InvestmentHighlight MedicalHomehealthOurea BiotechHL Partners II L.P.HL Partners II L.P.HL GP II Company LimitedHL GP II Company LimitedHL PartnersII L.P.HL GP II Company LimitedOurea Biotech (4)36.36%51.54%9,136,780H1,015,1985,114,645H568,294 (5)(i)4,144,199(ii)1,053,004 (6)239,427 (7)167,599 (8)71,828 20246 30XVXV78352 20246 30XVXV23336 (1)7,781,25720246 30324,619,744HL(2)IIWEA(3)WEA 100%WEA13,476,617HWEA13,476,617H(4)239,427(5)IIIIFiveInvestmentFive InvestmentHighlight MedicalHomehealthHighLight Capital Partners I L.P.HighLight Capital Partners I L.P.HighLight Capital GP I Company LimitedHighLight Capital Partners I L.P.HighLightCapital GP I Company LimitedFive InvestmentHighlight Medical HomehealthOurea BiotechHL Partners II L.P.HL Partners II L.P.HL GP II Company LimitedHL GP II CompanyLimitedHL Partners II L.P.HL GP II Company LimitedOurea Biotech(6)OAPIV(HK)LimitedOAPOrbiMedAsia Partners IV,L.P.OrbiMedAsia GP IV,L.P.OrbiMed Asia GP IV, L.P.OrbiMed Advisors IV LimitedOrbiMed Advisors IV LimitedSunny SharmaSven H. BorhoWilliam Carter Neild Jonathan T. Silverstein Carl L. GordonOrbiMed Asia Partners IV, L.P.OrbiMed Asia GP IV, L.P.OrbiMed Advisors IV LimitedSunny SharmaSvenH. BorhoWilliam Carter Neild Jonathan T. Silverstein Carl L. GordonOAP(7)40%(8)Lake Bleu Prime Healthcare Master Fund LimitedLakeBleu PrimeLBC Sunshine Healthcare Fund II L.P.LBC SunshineLBC Sunshine202463011,353,491HLake Bleu Prime41.253,763,000HLake Bleu Prime20246 306,699,500H18,052,991H (9)